Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes From EXCLAIM Extension Cohort Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Garcia Campelo, M. R.; Zhou, C.; Ramalingam, S.; Lin, H.; Kim, T.; Riely, G.; Mekhail, T.; Nguyen, D.; Goodman, E.; Le, K.; Mehta, M.; Popat, S.; Janne, P.

authors

Publication Date

  • October 1, 2021

webpage

published in

category

keywords

  • exon20 insertion
  • health-related quality of life
  • non-small cell lung cancer

start page

  • S960

end page

  • S961

volume

  • 16

issue

  • 10